SWOT Analysis
- S
- W
- O
- T
-
Strength (6)
Stocks with high EPS and EPS growth TTM and YoY
-
Weakness (3)
See all stocks where promoters decreased their stake. Promoters decreasing their shareholding in a stock is considered negative for the stock.
-
Opportunity (1)
FII / FPI or Institutions increasing their shareholding
-
Threats (0)
- Companies with high TTM EPS Growth
- Good quarterly growth in the recent results
- Growth in Net Profit with increasing Profit Margin (QoQ)
- Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
- Increasing profits every quarter for the past 4 quarters
- Book Value per share Improving for last 2 years
- FII / FPI or Institutions increasing their shareholding
Technical Analysis
Moving Averages
- 5 Day 484.5
- 10 Day 490.4
- 12 Day 492.8
- 20 Day 499.1
- 26 Day 500.9
- 50 Day 499.0
- 100 Day 485.2
- 200 Day 464.4
Current Price
- Bullish Moving Averages 9
- Bearish Moving Averages 7
Resistance and support
- First Resistance 497.7
- Second Resistance 504.2
- Third Resistance 514.9
- First Support 480.5
- Second Support 469.8
- Third Support 463.3
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
- CAGR IN 10 YEARS
- 11.95%
- 6.06%
- 3.62%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 8,422.39 | 7,302.31 | 6,345.67 | 6,565.08 | 6,040.18 |
|
| Operating Profit | 1,140.60 | 1,001.86 | 973.61 | 1,088.39 | 1,710.83 |
|
| OP Profit Margin | 13.54 | 13.72 | 15.34 | 16.58 | 28.32 |
|
| Interest | 338.62 | 275.24 | 210.66 | 165.80 | 101.54 |
|
| Profit After Tax | 422.31 | 339.65 | 417.35 | 545.78 | 1,182.05 |
|
| Cash Profit | 902.02 | 772.88 | 794.80 | 855.83 | 1,426.21 |
|
| EPS | 11.65 | 9.37 | 11.51 | 15.06 | 32.61 |
|
- CAGR IN 10 YEARS
- 18.36%
- 13.85%
- 15.25%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Equity | 181.30 | 181.26 | 181.25 | 181.25 | 181.25 |
|
| Reserve Surplus | 5,790.71 | 5,436.87 | 5,111.16 | 4,739.70 | 4,319.78 |
|
| TOT Debts | 4,964.93 | 3,846.39 | 3,621.82 | 2,907.26 | 2,581.25 |
|
| Gross Block | 8,877.33 | 8,371.99 | 7,239.35 | 6,261.08 | 5,036.00 |
|
| Capital Work In Progress | 2,187.00 | 1,456.73 | 1,229.05 | 1,095.97 | 1,303.02 |
|
| Cash Liquid Investment | 435.66 | 292.67 | 512.03 | 194.34 | 167.38 |
|
| Net Working Capital | 2,203.47 | 1,589.51 | 2,089.14 | 1,981.88 | 2,209.96 |
|
| Current Assets | 4,611.57 | 3,148.82 | 3,167.00 | 2,550.38 | 2,765.04 |
|
| Current Liabilities | 2,408.10 | 1,559.31 | 1,077.86 | 568.50 | 555.08 |
|
Jun 2026 (CR) |
Mar 2026 (CR) |
Dec 2025 (CR) |
Sep 2025 (CR) |
Jun 2025 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 2,001.00 | 2,222.00 | 2,103.00 | 1,934.00 | 1,444.00 |
|
| Gross Profit | 287.00 | 237.00 | 237.00 | 209.00 | 156.00 |
|
| Gross Profit Margins | 17.64 | 32.72 | 34.09 | 31.90 | 26.59 |
|
| Operating Profit | 366.00 | 349.00 | 303.00 | 284.00 | 212.00 |
|
| OP Profit Margin | 12.24 | 10.40 | 8.75 | 9.67 | 7.06 |
|
| Interest | 82.00 | 112.00 | 68.00 | 98.00 | 60.00 |
|
| Profit After Tax | 144.00 | 147.00 | 131.00 | 102.00 | 44.00 |
|
| Cash Profit | 268.00 | 265.00 | 252.00 | 222.00 | 158.00 |
|
| EPS | 3.98 | 4.05 | 3.63 | 2.77 | 1.20 |
|
- CAGR IN 10 YEARS
- 18.36%
- 13.85%
- 15.25%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| PE | 34.25 | 41.68 | 57.88 | 34.42 | 29.33 |
|
| P/BV | 2.42 | 2.52 | 4.56 | 3.82 | 7.70 |
|
| MCAP Sales | 1.72 | 1.94 | 3.81 | 2.86 | 5.74 |
|
| Asset Turnover | 0.89 | 0.86 | 0.81 | 0.94 | 0.99 |
|
| EV/EBITDA | 16.14 | 17.29 | 27.70 | 19.74 | 21.66 |
|
| DEBT/EQUITY | 0.76 | 0.68 | 0.64 | 0.58 | 0.69 |
|
| ROE | 7.29 | 6.23 | 8.17 | 11.59 | 29.88 |
|
| ROCE | 6.83 | 6.33 | 7.08 | 10.15 | 21.30 |
|
Quick Results Snapshot
Q1FY27 Quarterly Result Announced for Aarti Industries Ltd.
Specialty Chemicals company Aarti Industries announced Q1FY27 results
Consolidated Financial Highlights:
- Total Income for Q1FY27 stood at Rs 2,390 crore, recording a YoY growth of 42.35% compared to Rs 1,679 crore in Q1FY26 and a QoQ increase of 8.39% from Rs 2,205 crore in Q4FY26.
- Revenue from Operations (Net) for the quarter was Rs 2,387 crore, reflecting a YoY increase of 42.42% over Rs 1,676 crore in Q1FY26 and a QoQ increase of 8.20% over Rs 2,206 crore in Q4FY26.
- Profit before Exceptional Items and Tax for Q1FY27 reached Rs 178 crore, marking a significant YoY increase of 323.81% from Rs 42 crore in Q1FY26 and a QoQ growth of 60.36% from Rs 111 crore in Q4FY26.
- Profit before Tax (PBT) for Q1FY27 was Rs 180 crore, representing a YoY rise of 328.57% against Rs 42 crore in Q1FY26 and a QoQ increase of 62.16% from Rs 111 crore in Q4FY26.
- Net Profit for the period (attributable to owners of the company) stood at Rs 155 crore in Q1FY27, registering a YoY growth of 260.47% compared to Rs 43 crore in Q1FY26 and a QoQ increase of 13.14% from Rs 137 crore in Q4FY26.
Standalone Financial Highlights:
- Total Income for Q1FY27 was Rs 2,244 crore, showing a YoY growth of 36.75% from Rs 1,641 crore in Q1FY26 and a QoQ decline of 8.00% from Rs 2,439 crore in Q4FY26.
- Revenue from Operations (Net) for the quarter reached Rs 2,241 crore, up by 36.98% YoY compared to Rs 1,636 crore in Q1FY26, while declining 8.12% QoQ from Rs 2,439 crore in Q4FY26.
- Profit before Tax for Q1FY27 was Rs 163 crore, reflecting a YoY growth of 288.10% over Rs 42 crore in Q1FY26 and a QoQ growth of 36.97% over Rs 119 crore in Q4FY26.
- Net Profit for the period for Q1FY27 stood at Rs 144 crore, representing a YoY increase of 227.27% from Rs 44 crore in Q1FY26 and a slight QoQ decline of 2.04% from Rs 147 crore in Q4FY26.
Business Highlights:
- Divestment of Subsidiary: Aarti Corporate Services Limited ("ACSL"), a wholly-owned subsidiary, entered into an arrangement to divest its entire 100% equity stake in Shanti Intermediates Private Limited ("SIPL"). The transaction was completed w.e.f. June 23, 2026, for a consideration of Rs 2 crore. SIPL's share of Revenue and Net Profit to the company had been below 0.1%.
- Share Capital Allotment: During Q1FY27, the company issued and allotted 1,32,326 equity shares of Rs 5 each under the 'Aarti Industries Limited Performance Stock Option Plan 2022' ("PSOP 2022").
- Debt and Credit Rating: The company has retained its Long-Term Issuers & Bank Facilities credit ratings of AA/Negative from CRISIL and India Ratings. The Commercial Papers (Listed) outstanding as of June 30, 2026, were Rs 600 crore and are rated A1 by both India Rating and CRISIL.
- Corporate Structure: As of June 30, 2026, the company has 7 direct subsidiaries, 1 indirect subsidiary, and 2 joint ventures.
Suyog Kotecha, Chief Executive Officer & Executive Director, said: “We have begun FY27 with encouraging momentum, delivering healthy growth despite a dynamic global operating environment. Our performance reflects the strength of our diversified portfolio, disciplined execution and our ability to respond quickly to changing market conditions while continuing to serve customers seamlessly across geographies. While these disruptions affected Q1 volumes, we expect volumes to recover in Q2 as demand scenarios tend to improve.
During the quarter, we effectively managed geopolitical disruptions by leveraging our global market presence and operational flexibility. At the same time, we continued to advance our strategic growth agenda, with key expansion projects progressing as planned and customer engagements across new platforms gaining momentum. Our ability to manage inventory and global supply chain insulated us from a significant RM deficit and supported better pricing with customers.
While near-term macroeconomic uncertainties continue to persist, the fundamentals of our business remain strong. Our focus remains on executing our growth roadmap, improving operational efficiency, strengthening customer partnerships and creating sustainable long-term value. With our strategic investments nearing completion and new capacities expected to come on stream, we are well positioned to capture future opportunities and drive profitable growth.”
Stocks Comparison
Table
Chart
Company name |
LTP |
Market cap (Cr) |
Return (1Y %) |
Risk (Std. Dev.) |
PE Ratio |
Financial Year |
|---|---|---|---|---|---|---|
| Aarti Industries Ltd | 491.15 | 17,815.32 | 25.87 | 0.11 | 33.50 | Mar 2026 |
| Pidilite Industries Ltd | 1,572.10 | 160,020.87 | 2.68 | 0.06 | 59.57 | Mar 2026 |
| SRF Ltd | 2,512.00 | 74,461.92 | -14.79 | 0.05 | 35.12 | Mar 2026 |
| Linde India Ltd | 6,241.50 | 53,227.51 | -3.13 | 0.05 | 97.44 | Mar 2026 |
| Gujarat Fluorochemicals Ltd | 4,586.70 | 50,384.90 | 24.28 | - | 83.95 | Mar 2026 |
| Navin Fluorine International Ltd | 8,590.00 | 44,079.25 | 72.87 | 0.07 | 55.78 | Mar 2026 |
| Godrej Industries Ltd | 1,107.40 | 37,302.89 | -9.06 | 0.14 | 16.88 | Mar 2026 |
| Himadri Speciality Chemical Ltd | 675.35 | 34,076.42 | 44.34 | 0.14 | 42.30 | Mar 2026 |
| Deepak Nitrite Ltd | 1,586.30 | 21,636.03 | -14.02 | 0.14 | 27.99 | Mar 2026 |
| Aether Industries Ltd | 1,630.00 | 21,634.71 | 123.04 | 0.10 | 91.93 | Mar 2026 |
| Castrol India Ltd | 197.14 | 19,499.56 | -3.84 | 0.03 | 18.33 | Dec 2025 |
| Atul Ltd | 6,170.50 | 18,167.03 | -5.69 | 0.05 | 22.48 | Mar 2026 |
| Tata Chemicals Ltd | 693.25 | 17,661.24 | -31.03 | 0.14 | -8.96 | Mar 2026 |
| Deepak Fertilisers & Petrochemicals Corp Ltd | 1,343.20 | 16,956.26 | -8.20 | 0.15 | 17.22 | Mar 2026 |
| Fine Organic Industries Ltd | 5,199.00 | 15,940.12 | 5.74 | 0.10 | 36.43 | Mar 2026 |
| BASF India Ltd | 3,605.70 | 15,607.50 | -22.79 | 0.07 | 24.28 | Mar 2026 |
| Anupam Rasayan India Ltd | 1,207.70 | 13,749.65 | 9.31 | 0.06 | 61.01 | Mar 2026 |
| Privi Speciality Chemicals Ltd | 3,444.90 | 13,456.71 | 44.10 | 0.10 | 39.36 | Mar 2026 |
| PCBL Chemical Ltd | 336.70 | 13,247.89 | -14.19 | 0.12 | 51.18 | Mar 2026 |
| Vinati Organics Ltd | 1,234.90 | 12,801.67 | -27.50 | 0.04 | 28.58 | Mar 2026 |
| Sudarshan Chemical Industries Ltd | 1,263.50 | 10,059.53 | -11.22 | 0.14 | 112.58 | Mar 2026 |
| Jubilant Ingrevia Ltd | 624.90 | 9,953.48 | -12.93 | 0.14 | 32.25 | Mar 2026 |
| Alkyl Amines Chemicals Ltd | 1,863.00 | 9,528.91 | -11.02 | 0.11 | 42.37 | Mar 2026 |
| Clean Science & Technology Ltd | 851.90 | 9,054.34 | -28.75 | - | 38.82 | Mar 2026 |
| Gujarat Narmada Valley Fertilizers & Chemicals Ltd | 588.90 | 8,653.34 | 15.98 | 0.12 | 8.35 | Mar 2026 |
| Archean Chemical Industries Ltd | 467.15 | 5,767.36 | -34.72 | 0.09 | 60.23 | Mar 2026 |
| GHCL Ltd | 421.70 | 3,885.15 | -26.90 | 0.09 | 8.23 | Mar 2026 |
| Kiri Industries Ltd | 531.75 | 3,465.31 | -14.66 | 0.19 | 0.59 | Mar 2025 |
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 16, 2026Intimation of Analyst/Investor Meet
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sep 07, 2026Press Release titled "Aarti Industries Commissions Phase I of Zone IV Unlocking New High-Value Manufacturing Opportunities
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 28, 2026Newspaper Publication for dispatch of Integrated Annual Report for the FY 2025-26 and Notice of 43rd AGM
Aarti Industries Limited - Copy of Newspaper Publication
Aug 28, 2026Aarti Industries Limited has informed the Exchange about Copy of Newspaper Publication regarding dispatch to the Shareholders of Integrated Annual Report for the FY 2025-26 and Notice of 43rd AGM
Business Responsibility and Sustainability Reporting (BRSR)
Aug 27, 2026Please find attached BRSR for FY 2025-26
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aug 24, 2026Intimation of Analyst/Investor Meet.
Aarti Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Aug 24, 2026Aarti Industries Limited has informed the Exchange about Schedule of Analyst /Investor Meet.
| Ex-Date | Purpose | Notes |
|---|---|---|
| 2026-07-30 | Quarterly Results | |
| 2026-05-04 | Audited Results & Final Dividend | |
| 2026-02-02 | Quarterly Results | |
| 2025-11-06 | Quarterly Results | |
| 2025-07-31 | Quarterly Results | |
| 2025-05-08 | Audited Results & Dividend | |
| 2025-02-01 | Quarterly Results | |
| 2024-11-08 | Quarterly Results | |
| 2024-08-09 | Audited Results | |
| 2024-05-10 | Audited Results & Final Dividend | |
| 2024-02-08 | Quarterly Results | |
| 2023-11-04 | Quarterly Results | |
| 2023-08-08 | Quarterly Results | |
| 2023-05-08 | Audited Results & Final Dividend | |
| 2023-02-03 | Quarterly Results & Interim Dividend | |
| 2022-11-14 | Quarterly Results | |
| 2022-08-10 | Audited & Quarterly Results | |
| 2022-05-27 | Audited Results & Final Dividend | |
| 2022-02-05 | Quarterly Results & 2nd Interim Dividend | |
| 2021-10-30 | Quarterly Results & Interim Dividend | |
| 2021-08-19 | Scheme of Arrangement | |
| 2021-08-06 | Audited & Quarterly Results | |
| 2021-05-18 | Audited Results, Final Dividend & Bonus | (Revised) |
| 2021-05-11 | Audited Results, Final Dividend & Bonus | |
| 2021-01-28 | Quarterly Results | |
| 2020-11-10 | Quarterly Results & Interim Dividend | |
| 2020-08-12 | Quarterly Results | |
| 2020-05-25 | Audited Results & Final Dividend | |
| 2020-02-12 | Quarterly Results & Interim Dividend | |
| 2019-11-13 | Quarterly Results | |
| 2019-08-13 | Audited Results & Bonus issue | |
| 2019-07-08 | Others | inter alia, To consider, approve and take on record the Audited Financial Statements for the year ended March 31, 2019, post Composite Scheme of Arrangement. |
| 2019-05-21 | Audited Results, Final Dividend | |
| 2019-03-22 | Others | To consider and approve the issue price for Equity Shares to be allotted to the qualified institutional buyers in the proposed Issue, including a discount, if any. |
| 2019-02-03 | Quarterly Results & Interim Dividend | |
| 2018-11-01 | Quarterly Results & Others | |
| 2018-08-04 | Quarterly Results | |
| 2018-06-28 | Others | To consider and approve the Proposal for Composite Scheme of Arrangement between Aarti Industries Limited, Nascent Chemical Industries Ltd & Arti Surfactants Ltd & their respective shareholders. |
| 2018-05-11 | Audited Results & Final Dividend | |
| 2018-02-03 | Quarterly Results | |
| 2017-12-21 | Buy Back of Shares | |
| 2017-11-10 | Quarterly Results | |
| 2017-08-11 | Quarterly Results | |
| 2017-05-19 | Audited Results & Final Dividend | |
| 2017-02-06 | Quarterly Results | |
| 2016-11-11 | Quarterly Results | |
| 2016-10-17 | Buy Back of Shares | |
| 2016-08-10 | Quarterly Results | |
| 2016-05-06 | Audited Results | |
| 2016-03-14 | Third Interim Dividend | |
| 2016-02-05 | Quarterly Results & 2nd Interim Dividend | |
| 2015-11-05 | Quarterly Results & Interim Dividend | The Company has commissioned its full expanded Nitro Chloro Benzene capacities, of 75000 in November 2015. |
| 2015-09-24 | Others | Allotted 16,726,401 equity shares of Rs. 5/- (Rupees Five only) each in consideration of and in terms of Scheme of Amalgamation. |
| 2015-08-06 | Quarterly Results | |
| 2015-05-13 | Audited Results & Final Dividend | |
| 2015-02-09 | Quarterly Results & 2nd Interim Dividend | |
| 2014-11-08 | Quarterly Results & Interim Dividend | |
| 2014-08-11 | Quarterly Results | |
| 2014-05-30 | Audited Results & Final Dividend | |
| 2014-02-02 | Quarterly Results & 2nd Interim Dividend | |
| 2013-11-14 | Quarterly Results & Interim Dividend | |
| 2013-08-12 | Quarterly Results | |
| 2013-05-16 | Audited Results & Dividend | |
| 2013-02-06 | Quarterly Results & Interim Dividend | Second Interim Dividend |
| 2012-10-31 | Quarterly Results & Interim Dividend | |
| 2012-08-09 | Quarterly Results | |
| 2012-07-14 | Scheme of Arrangement | Inter alia, to consider and explore the possibility of Scheme of Arrangement for Merger or Demerger of Anushakti Chemicals and Drugs Limited, being an associate Company with the Company. |
| 2012-05-25 | Audited Results & Final Dividend | |
| 2012-02-09 | Others | The Board has consider the Sucession Plan post retirement of Shri. Chandrakant V Gogri as the Chairman of the Company w.e.f August 16, 2012 on his attaining the age of 66 years. |
| 2012-02-01 | Quarterly Results & Interim Dividend | |
| 2011-11-11 | Quarterly Results | |
| 2011-08-05 | Quarterly Results | |
| 2011-05-30 | Audited Results & Final Dividend | |
| 2011-02-02 | Quarterly Results & Interim Dividend | |
| 2010-11-11 | Quarterly Results | |
| 2010-08-10 | Quarterly Results | |
| 2010-05-26 | Quarterly Results & Final Dividend | |
| 2010-01-29 | Quarterly Results & Interim Dividend | |
| 2009-12-20 | Allotment of Equity Shares | The Board has allotted 30,25,000 Equity Shares of Rs. 5/- each fully paid up against exercise of option of Conversion by the holders of Convertible Warrants issued by the Co. on preferential basis. |
| 2009-10-30 | Quarterly Results | |
| 2009-09-12 | Audited Results & Dividend | To reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2009, post amalgamation of Avinash Drugs Ltd and Surfactant Specialties Ltd with the Company. |
| 2009-07-30 | Quarterly Results | |
| 2009-05-28 | Audited Results & Final Dividend | (Revised) |
| 2009-02-07 | To consider the Amalgamation | To consider the amalgamation of Avinash Drugs Ltd, Surfactant Specialities Ltd with the Company and to decide matters incidental thereto. |
| 2009-01-29 | Quarterly Results | |
| 2008-10-23 | Interim Dividend | |
| 2008-09-23 | To appoint Independent Director's | To appoint Mr. Prem Chandra Sethi, Mr. K V S Shyam Sunder and Mr. Bhavesh R Vora as Independent Directors of the Company. |
| 2008-07-31 | Quarterly Results & Others | To allot 30,25,000 convertible warrants on preferential basis to the promoters/ promoters group having face value equivalent to the 10% of the price of the said shares i.e at Rs. 3.565/- per warrants. |
| 2008-05-29 | Audited Results & Final Dividend | |
| 2008-01-28 | Quarterly Results & Interim Dividend | |
| 2007-10-31 | Quarterly Results | |
| 2007-07-31 | Quarterly Results | |
| 2007-06-19 | Audited Results & Final Dividend | |
| 2007-03-12 | Second Interim Dividend | |
| 2007-01-31 | Quarterly & Interim Dividend | |
| 2006-11-08 | Quarterly & Half Yearly Results | |
| 2006-07-29 | Quarterly Results | |
| 2006-05-20 | Accounts & Final Dividend | |
| 2006-02-15 | Second Interim Dividend | |
| 2006-01-30 | Quarterly Results | |
| 2005-10-31 | Quarterly Results & Interim Dividend | |
| 2005-08-01 | Quarterly Results | |
| 2005-05-11 | Final Dividend & Accounts | |
| 2005-02-02 | Second Interim Dividend | |
| 2005-01-24 | Quarterly Results | |
| 2004-12-29 | Bonus issue & Amalgamation | Bonus issue & Amalgamation of Aarti Healthcare Ltd. and Avinash Drug Ltd. (the subsidiaries of the company) |
| 2004-10-29 | Half Yearly Results | |
| 2004-07-28 | Accounts | |
| 2004-05-08 | Dividend & Accounts | |
| 2003-10-31 | Interim Dividend | |
| 2003-10-09 | Others | To obtain shareholders approval by postal Ballot in respect of sale of unit of the company situated at Turbhe. |
| 2003-07-31 | Quarterly Results | |
| 2003-06-19 | Accounts & Dividend | |
| 2003-01-31 | Quarterly Results | |
| 2002-11-29 | Half Yearly Results | |
| 2002-07-27 | Quarterly Results | |
| 2002-04-26 | Accounts | |
| 2002-03-09 | Interim Dividend | |
| 2002-01-25 | Quarterly Results | |
| 2001-10-31 | Accounts & Interim Dividend | |
| 2001-07-21 | Quarterly Results | |
| 2001-04-26 | Accounts, Dividend & Qtr Results | Revised. |
| 2001-04-25 | Accounts & Dividend | |
| 2001-01-25 | Dividend & Quarterly Results | Interim Dividend & Quarterly Results |
| 2000-10-19 | Quarterly Results | |
| 2000-04-18 | Accounts | |
| 2000-03-28 | 2nd Interim Dividend | |
| 2000-01-28 | Quarterly Results & Millennium Dividend | |
| 1999-07-28 | Quarterly Results | |
| 1999-01-29 | Quarterly Results | |
| 1998-10-30 | Quarterly Results | |
| 1998-06-24 | Accounts & Dividend | |
| 1997-11-20 | Half Yearly Results | |
| 1997-06-09 | Accounts |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 2026-09-11 | 1 | FINAL | 2026-09-14 | Equity Share |
| 2025-08-18 | 1 | FINAL | 2025-08-18 | Equity Share |
| 2024-07-26 | 1 | FINAL | 2024-07-26 | Equity Share |
| 2023-07-28 | 1.5 | FINAL | 2023-07-28 | Equity Share |
| 2023-02-15 | 1 | INTERIM | 2023-02-15 | Equity Share |
| 2022-09-16 | 1.5 | FINAL | 2022-09-19 | Equity Share |
| 2022-02-15 | 1 | INTERIM | 2022-02-16 | Equity Share |
| 2021-11-10 | 1 | INTERIM | 2021-11-11 | Equity Share |
| 2021-09-20 | 1.5 | FINAL | 2021-09-21 | Equity Share |
| 2020-11-19 | 1.5 | INTERIM | 2020-11-20 | Equity Share |
| 2020-09-10 | 1 | FINAL | 2020-09-11 | Equity Share |
| 2020-02-24 | 2.5 | INTERIM | 2020-02-25 | Equity Share |
| 2019-08-27 | 7 | FINAL | 2019-08-28 | Equity Share |
| 2019-02-12 | 4 | INTERIM | 2019-02-13 | Equity Share |
| 2018-09-11 | 1 | FINAL | Equity Share | |
| 2017-09-18 | 1 | FINAL | Equity Share | |
| 2016-03-22 | 3.5 | INTERIM | 2016-03-24 | Equity Share |
| 2016-02-12 | 2 | INTERIM | 2016-02-15 | Equity Share |
| 2015-11-09 | 3 | INTERIM | 2015-11-11 | Equity Share |
| 2015-09-15 | 1.75 | FINAL | Equity Share | |
| 2015-02-12 | 1.5 | INTERIM | 2015-02-15 | Equity Share |
| 2014-11-13 | 2.25 | INTERIM | 2014-11-14 | Equity Share |
| 2014-09-15 | 1.5 | FINAL | Equity Share | |
| 2014-02-06 | 1.25 | INTERIM | 2014-02-08 | Equity Share |
| 2013-11-19 | 1.75 | INTERIM | 2013-11-20 | Equity Share |
| 2013-09-12 | 1.25 | FINAL | Equity Share | |
| 2013-02-11 | 1.25 | INTERIM | 2013-02-12 | Equity Share |
| 2012-11-05 | 1.5 | INTERIM | 2012-11-06 | Equity Share |
| 2012-08-02 | 1.5 | FINAL | Equity Share | |
| 2012-02-06 | 2 | INTERIM | 2012-02-07 | Equity Share |
| 2011-09-16 | 1.25 | FINAL | Equity Share | |
| 2011-02-07 | 1.25 | INTERIM | 2011-02-08 | Equity Share |
| 2010-09-07 | 0.7 | FINAL | Equity Share | |
| 2010-02-03 | 1.8 | INTERIM | 2010-02-04 | Equity Share |
| 2009-09-29 | 1.2 | FINAL | Equity Share | |
| 2008-10-31 | 1.8 | INTERIM | 2008-11-03 | Equity Share |
| 2008-07-10 | 0.5 | FINAL | Equity Share | |
| 2008-02-01 | 1 | INTERIM | 2008-02-04 | Equity Share |
| 2007-03-20 | 0.3 | INTERIM | 2007-03-21 | Equity Share |
| 2007-02-13 | 0.5 | INTERIM | 2007-02-14 | Equity Share |
| 2006-09-18 | 0.4 | FINAL | Equity Share | |
| 2006-02-20 | 0.7 | INTERIM | 2006-02-21 | Equity Share |
| 2005-11-02 | 1.7 | INTERIM | 2005-11-07 | Equity Share |
| 2005-09-21 | 0.7 | FINAL | Equity Share | |
| 2005-02-09 | 4 | INTERIM | 2005-02-10 | Equity Share |
| 2004-11-03 | 4 | INTERIM | 2004-11-04 | Equity Share |
| 2004-07-20 | 4 | FINAL | Equity Share | |
| 2003-11-14 | 3.5 | INTERIM | 2003-11-17 | Equity Share |
| 2003-07-23 | 6.5 | FINAL | Equity Share |
| Ex-Date | Old FV | New FV | Record Date |
|---|---|---|---|
| 2006-01-13 | 10 | 5 | 2006-01-20 |
| Event Date | Event |
|---|---|
| Jun 22, 2021 | Bonus |
| Sep 27, 2019 | Bonus |
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
Client name |
Deal Type |
Date |
Action |
Avg. price |
Quantity |
Exchange |
|---|---|---|---|---|---|---|
| Graviton Research Capital Llp | Bulk | 2024-11-11 |
Purchase |
437.55 | 2,134,824 | NSE |
| Graviton Research Capital Llp | Bulk | 2024-11-11 |
Sell |
437.85 | 2,134,824 | NSE |
| Graviton Research Capital Llp | Bulk | 2024-08-13 |
Purchase |
632.95 | 1,938,900 | NSE |
| Graviton Research Capital Llp | Bulk | 2024-08-13 |
Sell |
633.15 | 1,938,900 | NSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-11-14 |
Purchase |
715.80 | 422,258 | NSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-11-14 |
Sell |
715.80 | 422,258 | NSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-11-03 |
Purchase |
723.80 | 422,259 | BSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-11-03 |
Sell |
723.80 | 422,259 | BSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-10-25 |
Purchase |
687.05 | 227,175 | BSE |
| Ishares Msci India Small-Cap Etf | Block | 2022-10-25 |
Purchase |
687.05 | 159,814 | BSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-10-25 |
Sell |
687.05 | 227,175 | BSE |
| Ishares India Sc Mauritius Company | Block | 2022-10-25 |
Sell |
687.05 | 159,814 | BSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-10-11 |
Purchase |
769.50 | 261,861 | BSE |
| Ishares Msci India Small-Cap Etf | Block | 2022-10-11 |
Purchase |
769.50 | 39,049 | BSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-10-11 |
Sell |
769.50 | 261,861 | BSE |
| Ishares India Sc Mauritius Company | Block | 2022-10-11 |
Sell |
769.50 | 39,049 | BSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-10-03 |
Purchase |
745.05 | 262,017 | NSE |
| Ishares Msci India Small-Cap Etf | Block | 2022-10-03 |
Purchase |
745.05 | 39,071 | NSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-10-03 |
Sell |
745.05 | 262,017 | NSE |
| Ishares India Sc Mauritius Company | Block | 2022-10-03 |
Sell |
745.05 | 39,071 | NSE |
| Ishares Core Msci Emerging Markets Etf | Block | 2022-09-19 |
Purchase |
884.80 | 178,115 | BSE |
| Ishares Msci India Small-Cap Etf | Block | 2022-09-19 |
Purchase |
884.80 | 26,349 | BSE |
| Ishares Core Emerging Markets Mauritius Co | Block | 2022-09-19 |
Sell |
884.80 | 178,115 | BSE |
| Ishares India Sc Mauritius Company | Block | 2022-09-19 |
Sell |
884.80 | 26,349 | BSE |
| Ishares Core Msci Total International Stock Etf | Block | 2022-05-04 |
Purchase |
847.65 | 216,355 | BSE |
| Ishares Core Total International Stock Mauritius Co | Block | 2022-05-04 |
Sell |
847.65 | 216,355 | BSE |
| Imco Emerging Markets Public Equity Lp | Block | 2021-12-20 |
Purchase |
969.95 | 522,610 | BSE |
| Ontario Pension Board | Block | 2021-12-20 |
Sell |
969.95 | 522,610 | BSE |
| Smallcap World Fund Inc | Bulk | 2020-06-15 |
Sell |
854.71 | 1,597,950 | NSE |
| Smallcap World Fund Inc | Bulk | 2020-06-15 |
Sell |
855.00 | 1,000,000 | BSE |
| The Vanguard Group Inc A/C Vanguard Emerg. Mkts Stock Inde | Bulk | 2019-03-15 |
Purchase |
1,425.32 | 416,418 | NSE |
| Hetal Gogri Gala | Bulk | 2018-03-28 |
Purchase |
1,144.00 | 1,709,327 | BSE |
| Chandrakant Vallabhaji Gogri | Bulk | 2018-03-28 |
Sell |
1,144.00 | 1,709,327 | BSE |
| Hetal Gogri Gala | Block | 2018-03-28 |
Purchase |
1,144.00 | 1,709,327 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2018-03-28 |
Sell |
1,144.00 | 1,709,327 | BSE |
| Rashesh Chandrakant Gogri | Bulk | 2018-03-26 |
Purchase |
1,057.00 | 649,602 | BSE |
| Chandrakant Vallabhaji Gogri | Bulk | 2018-03-26 |
Sell |
1,057.00 | 948,472 | BSE |
| Rashesh Chandrakant Gogri | Block | 2018-03-26 |
Purchase |
1,057.00 | 649,602 | BSE |
| Manisha Rashesh Gogri | Block | 2018-03-26 |
Purchase |
1,057.00 | 298,870 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2018-03-26 |
Sell |
1,057.00 | 649,602 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2018-03-26 |
Sell |
1,057.00 | 298,870 | BSE |
| Aashay Rashesh Gogri | Block | 2018-03-23 |
Purchase |
1,061.80 | 306,223 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2018-03-23 |
Sell |
1,061.80 | 306,223 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-31 |
Purchase |
755.00 | 253,217 | NSE |
| Jaya Chandrakant Gogri | Block | 2017-03-31 |
Sell |
755.00 | 253,217 | NSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-30 |
Purchase |
758.00 | 100,000 | NSE |
| Hetal Gogri Gala | Block | 2017-03-30 |
Sell |
758.00 | 100,000 | NSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-29 |
Purchase |
760.00 | 153,741 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-29 |
Purchase |
761.00 | 150,000 | NSE |
| Aashay Rashesh Gogri | Block | 2017-03-29 |
Sell |
760.00 | 153,741 | BSE |
| Jaya Chandrakant Gogri | Block | 2017-03-29 |
Sell |
761.00 | 150,000 | NSE |
| Chandrakant Vallabhaji Gogri | Bulk | 2017-03-28 |
Purchase |
775.00 | 414,996 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-28 |
Purchase |
775.00 | 308,340 | BSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-28 |
Purchase |
775.00 | 106,656 | BSE |
| Aashay Rashesh Gogri | Block | 2017-03-28 |
Sell |
775.00 | 308,340 | BSE |
| Aarnav Rashesh Gogri | Block | 2017-03-28 |
Sell |
775.00 | 106,656 | BSE |
| Chandrakant Vallabhaji Gogri | Bulk | 2017-03-27 |
Purchase |
780.00 | 5,139,602 | NSE |
| Mirik Rajendra Gogri | Bulk | 2017-03-27 |
Purchase |
777.38 | 600,000 | NSE |
| Hetal Gogri Gala | Bulk | 2017-03-27 |
Sell |
780.00 | 2,513,409 | NSE |
| Jaya Chandrakant Gogri | Bulk | 2017-03-27 |
Sell |
780.00 | 1,233,014 | NSE |
| Rashesh Chandrakant Gogri | Bulk | 2017-03-27 |
Sell |
780.00 | 951,059 | NSE |
| Aarti R Gogri | Bulk | 2017-03-27 |
Sell |
777.38 | 600,000 | NSE |
| Manisha Rashesh Gogri | Bulk | 2017-03-27 |
Sell |
780.00 | 442,120 | NSE |
| Chandrakant Vallabhaji Gogri | Block | 2017-03-27 |
Purchase |
780.00 | 5,139,602 | NSE |
| Hetal Gogri Gala | Block | 2017-03-27 |
Sell |
780.00 | 2,513,409 | NSE |
| Jaya Chandrakant Gogri | Block | 2017-03-27 |
Sell |
780.00 | 1,233,014 | NSE |
| Rashesh Chandrakant Gogri | Block | 2017-03-27 |
Sell |
780.00 | 951,059 | NSE |
| Manisha Rashesh Gogri | Block | 2017-03-27 |
Sell |
780.00 | 442,120 | NSE |
| Madan Dhanji Dedhia | Block | 2017-03-24 |
Purchase |
787.00 | 91,542 | BSE |
| Kalpen Madan Dedhia | Block | 2017-03-24 |
Sell |
787.00 | 91,542 | BSE |
| Renil Gogri | Bulk | 2017-03-23 |
Purchase |
782.50 | 600,000 | NSE |
| Rajendra Gogri | Bulk | 2017-03-23 |
Sell |
782.50 | 600,000 | NSE |
| Franklin Templeton Mutual Fund A/C Franklin India Prima Plus | Bulk | 2014-07-07 |
Purchase |
231.72 | 444,023 | NSE |
| Jaya Chandrakant Gogri | Bulk | 2014-07-07 |
Sell |
231.44 | 500,000 | NSE |
| Gogri And Sons Investments Pvt.Ltd | Bulk | 2013-07-30 |
Purchase |
76.75 | 597,349 | NSE |
| Alchemie Leasing &Amp; Financing Pvt Ltd | Bulk | 2013-07-30 |
Purchase |
76.75 | 450,632 | NSE |
| Alchemie Pharma Chem Ltd | Bulk | 2013-07-30 |
Sell |
76.75 | 983,051 | NSE |
| Rashesh C. Gogri | Bulk | 2012-01-19 |
Purchase |
48.65 | 400,000 | NSE |
| Dhanvanti Vallabhji Gogri | Bulk | 2012-01-19 |
Sell |
48.65 | 400,000 | NSE |
| Jaya Chandrakant Gogri | Bulk | 2012-01-10 |
Purchase |
49.00 | 435,494 | NSE |
| Dhanvanti Vallabhji Gogri | Bulk | 2012-01-10 |
Sell |
49.00 | 435,494 | NSE |
| Hetal Gogri Gala | Bulk | 2012-01-06 |
Purchase |
47.75 | 480,773 | NSE |
| Dilesh Roadlines Pvtltd | Bulk | 2012-01-06 |
Sell |
47.75 | 480,773 | NSE |
Client name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Avg. Price |
Regulation (Insider/SAST) |
Mode |
|---|---|---|---|---|---|---|---|---|
| Prasadi Yogesh Banatwala | Promoter |
Pledge |
2024-12-24 | 11,190 | 11,190 | SAST Reg31 | Creation | |
| Prasadi Yogesh Banatwala | Promoter |
Pledge |
2024-12-24 | 11,190 | 0 | SAST Reg31 | Release | |
| Bhavna Shah Lalka & Others | Promoter |
Disposal |
2024-07-12 | 6,230,240 | 156,738,924 | SAST 29(2) | Market / Gift | |
| Life Insurance Corporation Of India | Other |
Acquisition |
2022-04-26 | 224,000 | 18,254,335 | SAST 29(1) | Market | |
| Life Insurance Corporation Of India | Other |
Acquisition |
2022-04-26 | 224,000 | 18,254,335 | SAST 29(2) | Market Purchase | |
| Hdfc Mutual Fund | Other |
Disposal |
2021-12-02 | 174,221 | 11,033,886 | SAST 29(2) | Market |
About Aarti Industries Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Aarti Industries Ltd. is an Indian mid-cap corporation with a global presence that specialises in pharmaceutical and speciality chemicals production. It is valued at Rs 32,899 crores on the stock exchange. The company was founded on September 28, 1984, under the name Aarti Organics Ltd, but was later renamed Aarti Industries Ltd in 1994-95. Some of the preeminent names on the company's promoter list include Chandrakant V. Gogri, Shantilal T. Shah, and Rajendra V. Gogri. The company's remarkable performance is evidenced by its financials, which stood at Rs. 772 crores in the December quarter of the financial year 2021-22. Aarti Industries Ltd. shares trades under the scrip name of AARTIIND on both the Bombay Stock Exchange as well as the National Stock Exchange.
The product segment of Aarti Industries is currently divided into three categories: personal care, pharmaceuticals, and speciality chemicals. Its product portfolio comprises more than 200 products. Currently, the company operates 17 manufacturing facilities, the majority of which are in Western India. It also has three research and development facilities. The company's major source of revenue is speciality chemicals, which accounts for 78% of the total sales. The remaining 22% comes from sales of pharmaceuticals (15%) and home and personal care (7%) products. The company exports its goods to more than 60 countries, with Japan, China, the United States, and Europe being the most important markets.
Now let's have a look at the financials of Aarti Industries. The company's net income and revenue have outperformed the industry average during the last five years. During this time, the company's market share has also increased considerably. When comparing the December quarter income with the remaining two quarters of the financial year 2021-22, there is a major growth in the profit figure. The net income in the second quarter stood at 176.11 crores, but it increased by 596.38 crores in the third quarter.
On 29th March 2022, intraday closure, the Aarti Industries share price closed at Rs. 922.35. The Aarti Ind. share price saw a major fluctuation in the last twelve months. The 52-week high and low of the Aarti share price was reported at Rs. 1,105.25 and Rs. 655.05, respectively. The company's leading competitors are Gujarat Fluorochemicals Ltd., Vinati Organics Ltd., and Navin Fluorine International Ltd.
Disclaimer:- ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Aarti Industries share price as on 21 Sep 2026 is Rs. 491.15. Over the past 6 months, the Aarti Industries share price has increased by 15.58% and in the last one year, it has increased by 25.87%. The 52-week low for Aarti Industries share price was Rs. 338.05 and 52-week high was Rs. 551.75.
Plot Nos 801 801/23, GIDC Estate Phase III, VAPI, Gujarat, 396195
Tel No. 91-2638-55976666/25918195
Email investorrelations:aarti-industries.com
Chairman Emeritus
Non Executive Director
Independent Director
Independent Director
Vice Chairman
Executive Director & Chief Executive Officer
Independent Director
Chairman & Managing Director
Independent Director
Executive Director
Independent Director
Independent Director
Company Sec. & Compli. Officer
Whole-time Director
Vice Chairman & Managing Director
Non Executive & Independent Director
524208
AARTIIND
INE769A01020
Sep
Aarti Industries Ltd FAQs
You can buy Aarti Industries Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Industries Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 18, 2026 03:59 PM the closing price of Aarti Industries Ltd was Rs.491.15.
The latest PE ratio of Aarti Industries Ltd as of Sep 18, 2026 03:59 PM is 33.50
The latest PB ratio of Aarti Industries Ltd as of Sep 18, 2026 03:59 PM is 2.99
The 52-week high of Aarti Industries Ltd share price is Rs. 551.75 while the 52-week low is Rs. 338.05
According to analyst recommendations, Aarti Industries Ltd Share has a "Buy" rating for the long term.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 18, 2026 03:59 PM, the market cap of Aarti Industries Ltd stood at Rs. 17,815.34 Cr.
